Know Your Enemy: Potential Role of Cabergoline to Target Neoangiogenesis in Endometriosis

Antonio Simone Laganà, Simone Garzon, Jvan Casarin, Ricciarda Raffaelli, Antonella Cromi, Massimo Piergiuseppe Franchi, Fabio Ghezzi
Journal of investigative surgery : the official journal of the Academy of Surgical Research · 2020 · vol. 34(8) , pp. 902–903 · doi:10.1080/08941939.2020.1725191 · PMID:32046558 · W3006400327
Other OA: bronze CC0 ⤵ 4 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigates the potential of cabergoline, a dopamine D2 receptor agonist, to inhibit neoangiogenesis and thus treat endometriosis by targeting vascular endothelial growth factor A.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic inflammatory gynecologic disease characterized by the presence and growth of endometrial-like tissue outside the uterine cavity, with an estimated prevalence of 10% in re...

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Cabergoline Cabergoline Cabergoline Female Female Humans Humans Neovascularization, Pathologic Neovascularization, Pathologic Neovascularization, Pathologic

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (10)

Cited by (5)

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:26:40.963384+00:00
License: CC0 · commercial use OK